 Maria Cavasin
Concepts (272)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ventricular Remodeling | 14 | 2021 | 262 | 1.380 |
Why?
| | Myocardial Infarction | 10 | 2024 | 1041 | 0.920 |
Why?
| | Histone Deacetylases | 7 | 2018 | 215 | 0.900 |
Why?
| | Myocardium | 15 | 2024 | 1001 | 0.790 |
Why?
| | Oligopeptides | 5 | 2010 | 271 | 0.760 |
Why?
| | Hypertrophy, Right Ventricular | 3 | 2021 | 145 | 0.740 |
Why?
| | Histone Deacetylase Inhibitors | 6 | 2021 | 210 | 0.660 |
Why?
| | Receptors, Endothelin | 2 | 2014 | 51 | 0.640 |
Why?
| | Endothelin Receptor Antagonists | 2 | 2010 | 62 | 0.530 |
Why?
| | Hypertension, Pulmonary | 5 | 2021 | 1905 | 0.520 |
Why?
| | Phosphodiesterase 5 Inhibitors | 1 | 2014 | 37 | 0.450 |
Why?
| | Angiotensin II | 7 | 2021 | 99 | 0.440 |
Why?
| | Myocytes, Cardiac | 10 | 2025 | 523 | 0.410 |
Why?
| | Rats | 17 | 2022 | 5639 | 0.410 |
Why?
| | Heart | 4 | 2007 | 653 | 0.400 |
Why?
| | Cardiomegaly | 5 | 2016 | 175 | 0.400 |
Why?
| | Rats, Sprague-Dawley | 11 | 2019 | 2486 | 0.400 |
Why?
| | Transcription Factors | 4 | 2024 | 1718 | 0.350 |
Why?
| | Cell Proliferation | 4 | 2021 | 2475 | 0.350 |
Why?
| | Muscle, Smooth, Vascular | 2 | 2021 | 445 | 0.340 |
Why?
| | Heart Failure | 7 | 2022 | 2231 | 0.340 |
Why?
| | Blood Pressure | 10 | 2022 | 1774 | 0.340 |
Why?
| | Testosterone | 2 | 2005 | 401 | 0.340 |
Why?
| | Heart Ventricles | 6 | 2021 | 785 | 0.340 |
Why?
| | Animals | 38 | 2025 | 36847 | 0.340 |
Why?
| | Kidney | 5 | 2022 | 1467 | 0.330 |
Why?
| | Hemodynamics | 4 | 2018 | 1110 | 0.310 |
Why?
| | Thymosin | 2 | 2006 | 5 | 0.310 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 4 | 2004 | 201 | 0.300 |
Why?
| | Mice, Inbred C57BL | 12 | 2024 | 5749 | 0.290 |
Why?
| | Azepines | 3 | 2024 | 90 | 0.280 |
Why?
| | Liver Cirrhosis | 1 | 2010 | 316 | 0.280 |
Why?
| | Mice | 24 | 2025 | 17757 | 0.280 |
Why?
| | Nuclear Proteins | 2 | 2024 | 712 | 0.270 |
Why?
| | Vascular Remodeling | 2 | 2021 | 190 | 0.270 |
Why?
| | Serine Endopeptidases | 2 | 2007 | 123 | 0.270 |
Why?
| | Triazoles | 3 | 2024 | 147 | 0.270 |
Why?
| | Disease Models, Animal | 13 | 2024 | 4282 | 0.270 |
Why?
| | Glomerulosclerosis, Focal Segmental | 1 | 2007 | 47 | 0.260 |
Why?
| | Fibrosis | 7 | 2022 | 551 | 0.260 |
Why?
| | Nanotubes, Carbon | 1 | 2025 | 47 | 0.230 |
Why?
| | Ventricular Dysfunction, Left | 2 | 2018 | 382 | 0.220 |
Why?
| | Kidney Cortex | 1 | 2004 | 26 | 0.220 |
Why?
| | Myocardial Reperfusion Injury | 1 | 2024 | 134 | 0.210 |
Why?
| | Liver | 2 | 2010 | 1940 | 0.210 |
Why?
| | Pulmonary Artery | 2 | 2021 | 1086 | 0.200 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2024 | 368 | 0.200 |
Why?
| | Antihypertensive Agents | 3 | 2010 | 487 | 0.200 |
Why?
| | Macrophages | 6 | 2024 | 1544 | 0.200 |
Why?
| | Cells, Cultured | 7 | 2024 | 4191 | 0.200 |
Why?
| | Collagen | 7 | 2007 | 446 | 0.190 |
Why?
| | Myofibrils | 1 | 2022 | 49 | 0.190 |
Why?
| | Sarcomeres | 1 | 2022 | 95 | 0.190 |
Why?
| | Ramipril | 2 | 2001 | 6 | 0.190 |
Why?
| | Myocytes, Smooth Muscle | 2 | 2021 | 261 | 0.180 |
Why?
| | Gonadal Steroid Hormones | 1 | 2003 | 140 | 0.180 |
Why?
| | Dual-Specificity Phosphatases | 1 | 2021 | 11 | 0.180 |
Why?
| | Tetrazoles | 2 | 2001 | 40 | 0.180 |
Why?
| | Heart Murmurs | 1 | 2021 | 14 | 0.180 |
Why?
| | Biocompatible Materials | 1 | 2025 | 425 | 0.170 |
Why?
| | Angiotensin I | 1 | 2000 | 7 | 0.170 |
Why?
| | Tissue Engineering | 1 | 2025 | 418 | 0.170 |
Why?
| | Cell Cycle Proteins | 1 | 2024 | 613 | 0.170 |
Why?
| | Hydrogels | 2 | 2025 | 674 | 0.170 |
Why?
| | Imidazoles | 2 | 2001 | 238 | 0.170 |
Why?
| | Male | 25 | 2024 | 67311 | 0.160 |
Why?
| | Extracellular Matrix | 2 | 2021 | 528 | 0.160 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2022 | 543 | 0.160 |
Why?
| | Estradiol | 1 | 2003 | 518 | 0.160 |
Why?
| | Reperfusion Injury | 1 | 2022 | 279 | 0.150 |
Why?
| | Regional Blood Flow | 2 | 2012 | 473 | 0.150 |
Why?
| | Fibroblasts | 3 | 2024 | 993 | 0.150 |
Why?
| | Thermogenesis | 1 | 2018 | 44 | 0.150 |
Why?
| | Adipose Tissue, Brown | 1 | 2018 | 53 | 0.140 |
Why?
| | Cardiomyopathies | 1 | 2022 | 348 | 0.140 |
Why?
| | Myofibroblasts | 1 | 2019 | 126 | 0.140 |
Why?
| | Drug Discovery | 2 | 2016 | 141 | 0.140 |
Why?
| | Hypertension | 4 | 2011 | 1284 | 0.140 |
Why?
| | Mice, Knockout | 7 | 2024 | 3008 | 0.140 |
Why?
| | High-Throughput Screening Assays | 2 | 2016 | 158 | 0.130 |
Why?
| | Tryptophan Hydroxylase | 1 | 2016 | 53 | 0.130 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2019 | 455 | 0.130 |
Why?
| | Fatty Liver | 1 | 2018 | 243 | 0.120 |
Why?
| | Enzyme Inhibitors | 3 | 2016 | 839 | 0.120 |
Why?
| | Chromatin | 1 | 2019 | 519 | 0.120 |
Why?
| | Hypoxia | 2 | 2013 | 1112 | 0.120 |
Why?
| | Protease Inhibitors | 2 | 2007 | 107 | 0.120 |
Why?
| | Ventricular Function, Right | 1 | 2017 | 282 | 0.110 |
Why?
| | Transcription Factor CHOP | 1 | 2014 | 31 | 0.110 |
Why?
| | Captopril | 2 | 2004 | 11 | 0.110 |
Why?
| | Matrix Metalloproteinase 2 | 2 | 2004 | 56 | 0.110 |
Why?
| | Acute Kidney Injury | 1 | 2022 | 809 | 0.110 |
Why?
| | Matrix Metalloproteinase 9 | 2 | 2004 | 132 | 0.110 |
Why?
| | Ovariectomy | 2 | 2005 | 152 | 0.110 |
Why?
| | Muscular Atrophy | 1 | 2014 | 83 | 0.110 |
Why?
| | Stroke Volume | 4 | 2014 | 612 | 0.100 |
Why?
| | Adenylate Kinase | 1 | 2013 | 26 | 0.100 |
Why?
| | Histone Deacetylase 6 | 3 | 2022 | 17 | 0.100 |
Why?
| | Ventricular Function, Left | 3 | 2014 | 533 | 0.100 |
Why?
| | Calcinosis | 1 | 2014 | 235 | 0.100 |
Why?
| | Endoplasmic Reticulum | 1 | 2014 | 264 | 0.090 |
Why?
| | Vascular Diseases | 1 | 2014 | 243 | 0.090 |
Why?
| | Benzamides | 1 | 2012 | 216 | 0.090 |
Why?
| | Time Factors | 6 | 2014 | 6808 | 0.090 |
Why?
| | Portal Pressure | 1 | 2010 | 4 | 0.090 |
Why?
| | Receptor, Endothelin B | 1 | 2010 | 51 | 0.080 |
Why?
| | Connectin | 2 | 2022 | 32 | 0.080 |
Why?
| | Hepatic Stellate Cells | 1 | 2010 | 13 | 0.080 |
Why?
| | Receptor, Endothelin A | 1 | 2010 | 65 | 0.080 |
Why?
| | Hypertension, Portal | 1 | 2010 | 64 | 0.080 |
Why?
| | Gene Expression Regulation | 3 | 2018 | 2605 | 0.080 |
Why?
| | Heart Defects, Congenital | 1 | 2017 | 833 | 0.080 |
Why?
| | RNA-Binding Proteins | 1 | 2013 | 423 | 0.080 |
Why?
| | Carrier Proteins | 1 | 2013 | 769 | 0.080 |
Why?
| | Endothelin-1 | 1 | 2010 | 182 | 0.070 |
Why?
| | Nephrosclerosis | 1 | 2008 | 6 | 0.070 |
Why?
| | Peptides, Cyclic | 1 | 2010 | 259 | 0.070 |
Why?
| | Piperidines | 1 | 2010 | 206 | 0.070 |
Why?
| | Receptors, Chemokine | 1 | 2008 | 47 | 0.070 |
Why?
| | Pyrimidines | 1 | 2012 | 470 | 0.070 |
Why?
| | Female | 11 | 2022 | 72795 | 0.070 |
Why?
| | Pyridines | 1 | 2012 | 506 | 0.070 |
Why?
| | Sex Factors | 2 | 2022 | 2060 | 0.070 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2014 | 612 | 0.070 |
Why?
| | Heart Rate | 4 | 2007 | 820 | 0.070 |
Why?
| | Histones | 1 | 2013 | 636 | 0.070 |
Why?
| | Glomerular Mesangium | 1 | 2007 | 21 | 0.070 |
Why?
| | Random Allocation | 2 | 2008 | 353 | 0.070 |
Why?
| | Arginine Vasopressin | 1 | 2007 | 44 | 0.070 |
Why?
| | Substance P | 1 | 2007 | 36 | 0.070 |
Why?
| | Heart Function Tests | 2 | 2004 | 59 | 0.070 |
Why?
| | Heart Rupture | 2 | 2004 | 4 | 0.060 |
Why?
| | Indoles | 2 | 2014 | 410 | 0.060 |
Why?
| | Chronic Disease | 2 | 2004 | 1785 | 0.060 |
Why?
| | Sulfonamides | 1 | 2010 | 513 | 0.060 |
Why?
| | Castration | 1 | 2005 | 14 | 0.060 |
Why?
| | Hydroxamic Acids | 2 | 2018 | 89 | 0.060 |
Why?
| | Case-Control Studies | 3 | 2021 | 3539 | 0.060 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2017 | 283 | 0.060 |
Why?
| | Rupture | 1 | 2005 | 92 | 0.060 |
Why?
| | Reactive Oxygen Species | 1 | 2008 | 621 | 0.060 |
Why?
| | Gene Expression | 1 | 2010 | 1500 | 0.060 |
Why?
| | Obesity | 1 | 2018 | 2982 | 0.060 |
Why?
| | Hydroxyproline | 1 | 2004 | 21 | 0.060 |
Why?
| | Injections | 1 | 2025 | 183 | 0.060 |
Why?
| | Humans | 13 | 2025 | 136765 | 0.060 |
Why?
| | Thiazolidines | 1 | 2004 | 9 | 0.060 |
Why?
| | Neutrophil Infiltration | 1 | 2004 | 107 | 0.050 |
Why?
| | Heart Rupture, Post-Infarction | 1 | 2004 | 2 | 0.050 |
Why?
| | Growth Inhibitors | 1 | 2004 | 43 | 0.050 |
Why?
| | Signal Transduction | 4 | 2024 | 5076 | 0.050 |
Why?
| | Muscle, Skeletal | 1 | 2014 | 1710 | 0.050 |
Why?
| | Dipeptides | 1 | 2004 | 50 | 0.050 |
Why?
| | Epigenesis, Genetic | 2 | 2019 | 657 | 0.050 |
Why?
| | Particle Size | 1 | 2025 | 392 | 0.050 |
Why?
| | Thiazoles | 1 | 2004 | 123 | 0.050 |
Why?
| | Proline | 1 | 2004 | 79 | 0.050 |
Why?
| | Materials Testing | 1 | 2025 | 356 | 0.050 |
Why?
| | Models, Biological | 2 | 2013 | 1773 | 0.050 |
Why?
| | Organ Specificity | 1 | 2004 | 304 | 0.050 |
Why?
| | Nitriles | 1 | 2004 | 172 | 0.050 |
Why?
| | Nephrectomy | 1 | 2004 | 168 | 0.050 |
Why?
| | Orchiectomy | 1 | 2003 | 71 | 0.050 |
Why?
| | Glomerular Filtration Rate | 2 | 2022 | 745 | 0.050 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2022 | 152 | 0.050 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2025 | 247 | 0.050 |
Why?
| | Temperature | 1 | 2025 | 675 | 0.050 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2022 | 165 | 0.050 |
Why?
| | Elastic Modulus | 1 | 2022 | 123 | 0.050 |
Why?
| | Receptors, Bradykinin | 1 | 2001 | 5 | 0.050 |
Why?
| | Acute Disease | 1 | 2004 | 1006 | 0.050 |
Why?
| | Microscopy, Atomic Force | 1 | 2022 | 126 | 0.050 |
Why?
| | Cytoprotection | 1 | 2001 | 56 | 0.040 |
Why?
| | Models, Cardiovascular | 1 | 2002 | 195 | 0.040 |
Why?
| | Survival Rate | 1 | 2005 | 1963 | 0.040 |
Why?
| | Protein Isoforms | 2 | 2013 | 403 | 0.040 |
Why?
| | Transforming Growth Factor beta | 2 | 2019 | 480 | 0.040 |
Why?
| | NF-kappa B | 1 | 2024 | 691 | 0.040 |
Why?
| | Angiotensin Receptor Antagonists | 1 | 2001 | 92 | 0.040 |
Why?
| | Vasoconstrictor Agents | 1 | 2021 | 139 | 0.040 |
Why?
| | Protein Binding | 2 | 2019 | 2216 | 0.040 |
Why?
| | Interleukin-10 | 1 | 2022 | 302 | 0.040 |
Why?
| | Cardiac Output | 1 | 2000 | 164 | 0.040 |
Why?
| | Body Weight | 1 | 2004 | 985 | 0.040 |
Why?
| | Organ Size | 1 | 2000 | 477 | 0.040 |
Why?
| | Polymerase Chain Reaction | 2 | 2013 | 1059 | 0.040 |
Why?
| | Arrhythmias, Cardiac | 1 | 2022 | 333 | 0.040 |
Why?
| | Systole | 2 | 2014 | 189 | 0.040 |
Why?
| | Sex Characteristics | 1 | 2004 | 759 | 0.040 |
Why?
| | MAP Kinase Signaling System | 1 | 2021 | 320 | 0.040 |
Why?
| | Survival Analysis | 1 | 2002 | 1321 | 0.040 |
Why?
| | Nitric Oxide | 1 | 2004 | 915 | 0.040 |
Why?
| | Adipose Tissue, White | 1 | 2018 | 41 | 0.040 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2019 | 283 | 0.040 |
Why?
| | Cell Adhesion Molecules | 1 | 2019 | 181 | 0.040 |
Why?
| | Enhancer Elements, Genetic | 1 | 2019 | 190 | 0.040 |
Why?
| | Echocardiography | 1 | 2000 | 642 | 0.030 |
Why?
| | Myosins | 1 | 2018 | 132 | 0.030 |
Why?
| | Drug Therapy, Combination | 2 | 2014 | 1062 | 0.030 |
Why?
| | Diet, High-Fat | 1 | 2018 | 247 | 0.030 |
Why?
| | Inflammation | 2 | 2008 | 2835 | 0.030 |
Why?
| | Isoenzymes | 1 | 2017 | 304 | 0.030 |
Why?
| | Phenotype | 1 | 2024 | 3189 | 0.030 |
Why?
| | RNA Polymerase II | 1 | 2019 | 324 | 0.030 |
Why?
| | Molecular Imaging | 1 | 2016 | 53 | 0.030 |
Why?
| | Small Molecule Libraries | 1 | 2016 | 94 | 0.030 |
Why?
| | Animals, Newborn | 1 | 2017 | 844 | 0.030 |
Why?
| | Ketocholesterols | 1 | 2014 | 7 | 0.030 |
Why?
| | Ezetimibe | 1 | 2014 | 24 | 0.030 |
Why?
| | Serotonin | 1 | 2016 | 323 | 0.030 |
Why?
| | Azetidines | 1 | 2014 | 43 | 0.030 |
Why?
| | Simvastatin | 1 | 2014 | 61 | 0.030 |
Why?
| | Apolipoproteins E | 1 | 2014 | 83 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2016 | 729 | 0.030 |
Why?
| | Immunoblotting | 1 | 2013 | 306 | 0.030 |
Why?
| | Adaptation, Physiological | 1 | 2017 | 549 | 0.030 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2013 | 42 | 0.030 |
Why?
| | Transcriptome | 1 | 2019 | 969 | 0.030 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2013 | 138 | 0.020 |
Why?
| | Energy Metabolism | 1 | 2018 | 919 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 346 | 0.020 |
Why?
| | Cell Cycle | 1 | 2013 | 601 | 0.020 |
Why?
| | Adenoviridae | 1 | 2011 | 193 | 0.020 |
Why?
| | Cardiovascular Diseases | 2 | 2014 | 2104 | 0.020 |
Why?
| | Atherosclerosis | 1 | 2014 | 415 | 0.020 |
Why?
| | Insulin Resistance | 1 | 2018 | 1203 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2013 | 1180 | 0.020 |
Why?
| | Lipids | 1 | 2014 | 665 | 0.020 |
Why?
| | RNA Interference | 1 | 2011 | 466 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2011 | 622 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2016 | 3265 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2002 | 10745 | 0.020 |
Why?
| | Probability | 1 | 2008 | 304 | 0.020 |
Why?
| | Albuminuria | 1 | 2008 | 185 | 0.020 |
Why?
| | Reference Values | 1 | 2008 | 816 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2018 | 7585 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2013 | 1982 | 0.020 |
Why?
| | Blotting, Western | 1 | 2008 | 1225 | 0.010 |
Why?
| | Neovascularization, Pathologic | 1 | 2007 | 301 | 0.010 |
Why?
| | Middle Aged | 2 | 2018 | 33228 | 0.010 |
Why?
| | NG-Nitroarginine Methyl Ester | 1 | 2004 | 48 | 0.010 |
Why?
| | Renal Circulation | 1 | 2004 | 58 | 0.010 |
Why?
| | Connective Tissue Growth Factor | 1 | 2004 | 25 | 0.010 |
Why?
| | Immediate-Early Proteins | 1 | 2004 | 49 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2008 | 1733 | 0.010 |
Why?
| | Cell Movement | 1 | 2008 | 968 | 0.010 |
Why?
| | Kidney Glomerulus | 1 | 2004 | 114 | 0.010 |
Why?
| | Lung | 1 | 2016 | 4062 | 0.010 |
Why?
| | Nitric Oxide Synthase | 1 | 2004 | 240 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2008 | 1935 | 0.010 |
Why?
| | Infant | 1 | 2017 | 9395 | 0.010 |
Why?
| | Rats, Inbred WKY | 1 | 2003 | 36 | 0.010 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2004 | 130 | 0.010 |
Why?
| | Rats, Inbred SHR | 1 | 2003 | 45 | 0.010 |
Why?
| | Mast Cells | 1 | 2004 | 147 | 0.010 |
Why?
| | Diastole | 1 | 2003 | 149 | 0.010 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2004 | 382 | 0.010 |
Why?
| | Cell Division | 1 | 2004 | 796 | 0.010 |
Why?
| | Mice, Transgenic | 1 | 2007 | 2163 | 0.010 |
Why?
| | Receptor, Bradykinin B2 | 1 | 2001 | 4 | 0.010 |
Why?
| | Receptor, Angiotensin, Type 2 | 1 | 2001 | 9 | 0.010 |
Why?
| | Receptor, Angiotensin, Type 1 | 1 | 2001 | 25 | 0.010 |
Why?
| | Monocytes | 1 | 2004 | 563 | 0.010 |
Why?
| | Mice, Inbred Strains | 1 | 2001 | 409 | 0.010 |
Why?
| | Aged | 1 | 2018 | 23794 | 0.010 |
Why?
| | Neutrophils | 1 | 2004 | 1236 | 0.010 |
Why?
| | Adolescent | 1 | 2017 | 21382 | 0.010 |
Why?
| | DNA | 1 | 2004 | 1458 | 0.010 |
Why?
| | Child | 1 | 2017 | 21819 | 0.010 |
Why?
| | Adult | 1 | 2018 | 37631 | 0.010 |
Why?
| | Disease Progression | 1 | 2001 | 2750 | 0.010 |
Why?
| | Biomarkers | 1 | 2004 | 4144 | 0.010 |
Why?
|
|
Cavasin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|